News Archive

2011

ThermoGenesis Reports First Quarter Fiscal Year 2012 Results November 10, 2011 more>

ThermoGenesis Corp. to Announce First Quarter Fiscal 2012 Results on November 10, 2011 November 08, 2011 more>

ThermoGenesis Announces Acceptance of AXP® Submission by Regulatory Body in China October 11, 2011 more>

ThermoGenesis Reports Fourth Quarter and Year End 2011 Results; Annual Net Loss Reduced by More Than 50 Percent September 12, 2011 more>

ThermoGenesis Presentation at Rodman & Renshaw Conference September 07, 2011 more>

ThermoGenesis Corp. to Announce Fourth Quarter and Year End Results for Fiscal 2011 on September 12, 2011 September 06, 2011 more>

ThermoGenesis Names Former Applied Imaging CEO Robin Stracey to Board of Directors, Replacing Dr. Mahendra Rao August 01, 2011 more>

ThermoGenesis Announces Webcast of Presentation at OnemedForum Conference June 16, 2011 more>

ThermoGenesis Announces 510(k) Approval for Use of Res-Q in Preparation of Platelet Rich Plasma June 02, 2011 more>

ThermoGenesis Reports Third Quarter Fiscal 2011 Results; Major Progress Achieved in China & India May 05, 2011 more>

ThermoGenesis Corp. to Announce Third Quarter Fiscal 2011 Results On May 5, 2011 April 29, 2011 more>

ThermoGenesis Announces China Customer Implements Cord Blood Products April 27, 2011 more>

ThermoGenesis Announces Registration of Res-Q in India; Commercial Sales Expected to Begin in Current Quarter April 13, 2011 more>

Major China Regenerative Medicine Company Adopts ThermoGenesis Cord Blood Stem Cell Processing And Storage Technologies March 30, 2011 more>

ThermoGenesis Announces Pricing Of Offering March 04, 2011 more>

ThermoGenesis Announces Agreement for AXP and BioArchive Cord Blood Systems With Major Chinese Stem Cell Company February 10, 2011 more>

ThermoGenesis Reports Second Quarter 2011 Results; Increased Presence in China February 10, 2011 more>

ThermoGenesis Corp. to Announce Second Quarter Fiscal 2011 Results on February 10, 2011 February 02, 2011 more>

ThermoGenesis Corp. and TotipotentSC Receive Approval for Phase Ib Clinical Trial of Res-Q™ 60 BMC for Treatment of Critical Limb Ischemia January 26, 2011 more>

ThermoGenesis Corp. Files Shelf Registration Statement on Form S-3 January 06, 2011 more>

2010

ThermoGenesis Signs Major Bone Marrow Product Distribution Agreement in China November 04, 2010 more>

ThermoGenesis Reports 35 Percent Increase in First Quarter 2011 Revenues, Adds Strategic Advisor and Inks China Distribution Deal With Nanshan Memorial Medical Institute November 04, 2010 more>

ThermoGenesis Announces Platelet Rich Plasma (PRP) Res-Q Cardiovascular Licensing Agreement October 19, 2010 more>

ThermoGenesis Announces Fourth Quarter Revenues of $7.2 Million; Reduces Net Loss to $171,000 September 14, 2010 more>

ThermoGenesis Regains Compliance With NASDAQ Listing Rules September 13, 2010 more>

Current Clinical Findings on the Therapeutic Use of Concentrated Bone Marrow-Derived Stem Cells Will be Presented During ThermoGenesis Symposium at Leading Cellular Therapy Meeting in Europe September 08, 2010 more>

ThermoGenesis Corp. to Announce Fourth Quarter and Year End Results for Fiscal 2010 on September 14, 2010 September 07, 2010 more>

ThermoGenesis Announces Sale of BioArchive Systems In Asia as Company Increases Presence In Key Market August 30, 2010 more>

ThermoGenesis Announces Reverse Stock Split Effective on NASDAQ Capital Market August 27, 2010 August 26, 2010 more>

ThermoGenesis Announces Stockholder Authorization of Reverse Split August 11, 2010 more>

ThermoGenesis Announces Completion of Second Source Manufacturing for AXP® Bag Sets August 04, 2010 more>

ThermoGenesis Announces Preliminary Fourth Quarter 2010 Financial Results; Revenues Expected to Exceed $7 Million July 19, 2010 more>

ThermoGenesis Announces It Will Seek Stockholder Approval for Reverse Stock Split June 18, 2010 more>

ThermoGenesis Announces Agreement Related to Plan for Divestiture of CryoSeal(R) Product Line June 16, 2010 more>

ThermoGenesis Reports Fiscal 2010 Third Quarter Results May 06, 2010 more>

ThermoGenesis Names Leading Healthcare Industry Executive David Carter To Board Of Directors May 06, 2010 more>

ThermoGenesis Announces Global Res-Q Distribution Agreement With GE Healthcare May 06, 2010 more>

ThermoGenesis Corp. To Announce Third Quarter Fiscal 2010 Results On May 6, 2010 May 03, 2010 more>

ThermoGenesis Extends Global Reach for Bone Marrow Products With New Distribution Agreements April 26, 2010 more>

ThermoGenesis Signs Asia Distribution Agreement With Fenwal For BioArchive And AXP Systems March 16, 2010 more>

ThermoGenesis Announces Major Strategic Development With Completion Of New Distribution Agreement With GE Healthcare February 04, 2010 more>

ThermoGenesis Reports Significant Improvement In Sequential Financial Results For Second Quarter Fiscal 2010; Revenues Increase 15 Percent And Net Loss Reduced 33 Percent Versus First Quarter Fiscal 2010 February 04, 2010 more>

ThermoGenesis Corp. to Announce Second Quarter Fiscal 2010 Results on February 4, 2010; Company Will Provide Update on Distributor Relationships January 27, 2010 more>

2009

ThermoGenesis Corp. Names Healthcare Industry Executive Craig Moore To Board Of Directors December 10, 2009 more>

ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program; Company Provides Update On Key Corporate Initiatives December 07, 2009 more>

ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line November 05, 2009 more>

ThermoGenesis Names Jorge Artiles Vice President, Chief Quality and Regulatory Affairs Officer October 19, 2009 more>

Celling Technologies Announces Initial Success With Res-Q System in Adult Stem Cell Therapy Procedures October 13, 2009 more>

ThermoGenesis Corp. Receives Notice Related To NASDAQ Minimum Closing Bid Price Rule September 21, 2009 more>

ThermoGenesis Corp. Reports Fourth Quarter And Fiscal 2009 Results September 09, 2009 more>

ThermoGenesis Corp. To Announce Fourth Quarter And Year End Results On September 9; Company Provides Presentation Details For Rodman & Renshaw Conference To Be Webcast September 08, 2009 more>

ThermoGenesis Names Harold ('Hal') Baker Vice President of Sales August 10, 2009 more>

ThermoGenesis Announces Expanded Collaboration With Celling Technologies August 06, 2009 more>

ThermoGenesis Announces Launch Of Res-Q System August 06, 2009 more>

ThermoGenesis Provides Update On Fiscal 2009 Results August 06, 2009 more>

ThermoGenesis Appoints Chief Executive Officer J. Melville ('Mel') Engle to Board of Directors June 10, 2009 more>

ThermoGenesis Announces National Institute Of Health Grant June 09, 2009 more>

ThermoGenesis Reports Third Quarter Results May 06, 2009 more>

ThermoGenesis Corp. To Announce Third Quarter Fiscal 2009 Results On May 6, 2009 May 01, 2009 more>

ThermoGenesis Names 30-Year Healthcare Industry Executive J. Melville (“Mel”) Engle Chief Executive Officer April 14, 2009 more>

ThermoGenesis Announces Abstracts To Be Presented At Upcoming Stem Cell Therapy Conference April 02, 2009 more>

ThermoGenesis Technology Products Surpass Processing Of More Than One Million Units Of Cord Blood Stem Cells At 10-Year Milestone March 02, 2009 more>

ThermoGenesis Says FDA Concurs With Plan For Previously Announced AXP™ Bagset Recall February 26, 2009 more>

ThermoGenesis Reports Second Quarter Results February 04, 2009 more>

ThermoGenesis Announces MXP Involvement in New Regenerative Medicine Initiatives January 29, 2009 more>

ThermoGenesis Corp. To Announce Second Quarter Fiscal 2009 Results On February 4, 2009 January 29, 2009 more>

2008

ThermoGenesis Introduces New Cell Separation Technology For Veterinary Use At Major Equine Convention December 10, 2008 more>

ThermoGenesis Corp. Provides Updated Information For Conference Call/Webcast To Discuss Management Transition December 05, 2008 more>

ThermoGenesis Corp. Announces Management Transition; Provides Update On Operational Milestones December 03, 2008 more>

ThermoGenesis Corp. Schedules Conference Call/Webcast To Discuss Management Transition December 03, 2008 more>

ThermoGenesis Corp. Reports First Quarter 2009 Results November 07, 2008 more>

ThermoGenesis Corp. Presentation At Rodman & Renshaw Conference November 07, 2008 more>

ThermoGenesis Corp. To Announce First Quarter Fiscal 2009 Results On November 6, 2008 October 31, 2008 more>

ThermoGenesis Corp. Announces Distribution Agreement For Bone Marrow Stem Cell Device September 09, 2008 more>

ThermoGenesis Corp. Reports Record Quarterly Revenues Of $7.2 Million; Full Year Revenues Increase 31 Percent September 09, 2008 more>

ThermoGenesis Corp. To Announce Fourth Quarter And Year End Results For Fiscal 2008 On September 9, 2008 September 03, 2008 more>

ThermoGenesis Names Tiffany Olson To Board Of Directors August 06, 2008 more>

ThermoGenesis Announces 10 New BioArchive System Distributors July 24, 2008 more>

ThermoGenesis Announces FDA Authorization to Market MarrowXpress(TM) (MXP(TM)) July 14, 2008 more>

ThermoGenesis Announces Receipt of CE Mark for MarrowXpress June 19, 2008 more>

ThermoGenesis Announces Filing of 510 (k) Application for MarrowXpress June 04, 2008 more>

Thermogenesis Corp. Announces Third Quarter Fiscal 2008 Results May 07, 2008 more>

Thermogenesis Announces Amended and Restated Distribution Agreement With GE Healthcare May 07, 2008 more>

ThermoGenesis Names Dr. Mahendra Rao To Board Of Directors March 12, 2008 more>

ThermoGenesis Subsidiary Vantus Announces Stem Cell Agreement With UC Davis Center For Equine Health February 27, 2008 more>

ThermoGenesis Corp. Announces Voluntary Recall Of Selected Lots Of AXP Bag Sets February 22, 2008 more>

ThermoGenesis Announces New Initiative To Address Veterinary Regenerative Medicine February 06, 2008 more>

ThermoGenesis Corp. To Announce Second Quarter Fiscal 2008 Results On February 6, 2008 January 30, 2008 more>

ThermoGenesis Corp. Provides Update On Second Fiscal Quarter January 10, 2008 more>

2007

ThermoGenesis Corp. To Announce First Quarter Fiscal 2008 Results On November 8, 2007 November 08, 2007 more>

ThermoGenesis Announces 510(k) Clearance for AutoXpress™ Cord Blood Processing System October 09, 2007 more>

ThermoGenesis Corp. Reports Fourth Quarter And Fiscal Year 2007 Results September 12, 2007 more>

ThermoGenesis Corp. To Announce Fourth Quarter & Year End Results For Fiscal Year 2007 On September 12, 2007 September 05, 2007 more>

ThermoGenesis Corp. Appoints William Osgood Chief Executive Officer And Director July 30, 2007 more>

ThermoGenesis Corp. Announces Preliminary Fiscal 2007 Revenues; Company Announces Agreement With Nipro Corporation To Supply AutoXpress™ (AXP™) Platform Disposables July 30, 2007 more>

Thermogenesis and University of California, Davis Stem Cell Program Collaborate to Develop Stem Cell Treatments for Major Diseases June 19, 2007 more>

Thermogenesis Corp. To Announce Third Quarter Fiscal 2007 Results On May 10, 2007 May 01, 2007 more>

ThermoGenesis Announces Record Revenues and Key Executive Changes April 25, 2007 more>

ThermoGenesis Corp. Granted Three Additional Patents by the U.S. Patent & Trademark Office March 12, 2007 more>

ThermoGenesis Announces Higher Production Volumes for AutoXpress™ (AXP™) Cord Blood Stem Cell Processing Bags March 02, 2007 more>

ThermoGenesis Corp. Names cell therapy device sales expert Daniel A. Segal as Vice President of Sales & Marketing February 15, 2007 more>

Thermogenesis Corp. Submits 510(K) application to FDA for AUTOXPRESS™ Cord Blood Processing System February 08, 2007 more>

ThermoGenesis Corp. submits response to FDA on CRYOSEAL® U.S. Pre-Market Approval Application February 06, 2007 more>

ThermoGenesis Corp. to announce Second Quarter Fiscal 2007 results on February 9, 2007 February 02, 2007 more>

ThermoGenesis Corp. to present at International Stem Cells and Regenerative Medicine 2007 meeting January 19, 2007 more>

ThermoGenesis Corp. Appoints industry veteran William Osgood as General Manager of Operations January 03, 2007 more>